• 1. Achieving high-efficiency purely organic room-temperature phosphorescence materials by boronic ester substitution of phenoxathiine?
  Mengke Li,Xinyi Cai,Zhenyang Qiao,Wentao Xie,Liangying Wang,Nan Zheng,Shi-Jian Su Chem. Commun., 2019,55, 7215-7218
• 2. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 3. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. Aggregation-induced emission enhancement of carbon quantum dots and applications in light emitting devices
  Rongyan Guo,Tao Li,Shuie Shi J. Mater. Chem. C, 2019,7, 5148-5154

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Professional Introduction to 1,4-dihydro-4-oxo-3-Pyridinecarboxylic acid methyl ester (CAS No. 67367-25-3) in Modern Chemical and Pharmaceutical Research

The compound 1,4-dihydro-4-oxo-3-Pyridinecarboxylic acid methyl ester, identified by the CAS number 67367-25-3, represents a significant molecule in the realm of chemical and pharmaceutical innovation. This heterocyclic ester, characterized by its pyridine core and ester functional group, has garnered attention due to its versatile structural framework and potential applications in drug discovery and synthetic chemistry. The systematic name underscores its chemical composition: a dihydropyridone derivative with a carboxymethyl ester at the 3-position.

Recent advancements in medicinal chemistry have highlighted the importance of pyridine derivatives in developing novel therapeutic agents. The structural motif of 1,4-dihydro-4-oxo-3-Pyridinecarboxylic acid methyl ester offers a unique platform for modulating biological targets, particularly in the inhibition of enzymes and receptors involved in inflammatory and metabolic pathways. Its dihydropyridone scaffold is reminiscent of molecules known for their vasodilatory and calcium channel modulation properties, though the ester functionality introduces additional reactivity that can be leveraged for prodrug design or bioconjugation strategies.

In the context of contemporary research, this compound has been explored as a precursor for more complex molecules. The ester group at the 3-position of the pyridine ring provides a reactive site for further derivatization, enabling chemists to introduce diverse substituents that can fine-tune pharmacokinetic and pharmacodynamic profiles. Such modifications are critical in optimizing drug candidates for clinical translation, where factors such as solubility, bioavailability, and metabolic stability must be carefully considered.

One particularly intriguing application of 1,4-dihydro-4-oxo-3-Pyridinecarboxylic acid methyl ester lies in its potential role as an intermediate in the synthesis of kinase inhibitors. Pyridine-based inhibitors have demonstrated efficacy against various kinases implicated in cancer and inflammatory diseases. The dihydropyridone core can serve as a hinge-binding motif, interacting with critical residues within the ATP-binding pocket of these enzymes. Additionally, the presence of an ester group allows for modifications that could enhance binding affinity or selectivity, making it a valuable building block in structure-based drug design.

Another area where this compound has shown promise is in the development of antimicrobial agents. The pyridine ring is a common structural feature in many antibiotics and antifungals due to its ability to engage with biological targets through hydrogen bonding and hydrophobic interactions. Researchers have recently reported on the use of related dihydropyridone derivatives as scaffolds for novel antimicrobial compounds. By incorporating functional groups such as halogens or nitrogen heterocycles into the core structure, chemists can generate molecules with enhanced activity against resistant strains of bacteria or fungi.

The synthesis of 1,4-dihydro-4-oxo-3-Pyridinecarboxylic acid methyl ester itself presents an interesting challenge from a synthetic chemistry perspective. Traditional approaches often involve multi-step sequences that require careful control of reaction conditions to avoid side products. However, recent methodologies have focused on streamlined synthetic routes that minimize purification steps while maintaining high yields. These advances are particularly important in industrial settings where cost-effectiveness and scalability are paramount considerations.

From a computational chemistry standpoint, 1,4-dihydro-4-oxo-3-Pyridinecarboxylic acid methyl ester has been subjected to extensive molecular modeling studies to elucidate its interactions with biological targets. These studies not only help predict binding affinities but also provide insights into how structural modifications might improve drug-like properties. For instance, virtual screening campaigns have identified novel analogs based on this scaffold that exhibit enhanced potency or selectivity against specific enzymes or receptors.

The role of this compound in prodrug formulations is another emerging field of interest. Prodrugs are designed to improve the delivery or absorption of active pharmaceutical ingredients (APIs) by converting them into inactive forms that are later metabolized into their active form within the body. The ester functionality of 1,4-dihydro-4-oxo-3-Pyridinecarboxylic acid methyl ester makes it an ideal candidate for prodrug development, as esters can be hydrolyzed under physiological conditions to release the parent molecule.

In conclusion,1,4-dihydro-4-oxo-3-Pyridinecarboxylic acid methyl ester (CAS No. 67367-25-3) represents a versatile and valuable compound with numerous applications across chemical biology and pharmaceutical research. Its unique structural features—combining a dihydropyridone core with an ester group—make it an attractive scaffold for drug discovery efforts aimed at modulating enzyme activity, improving antimicrobial efficacy, or developing advanced prodrug systems. As synthetic methodologies continue to evolve and computational tools become more sophisticated, this compound is poised to play an increasingly important role in next-generation therapeutics.

• 67367-24-2(Methyl 4-hydroxynicotinate)
• 89193-23-7(ethyl 2-(dimethylamino)methylidene-3-oxopentanoate)
• 74632-26-1(3-Pyridinecarboxylicacid, 1,4-dihydro-5-methyl-4-oxo-)
• 10177-34-1(Ethyl 4-hydroxynicotinate)
• 51145-57-4(ethyl 2-(dimethylaminomethylene)-3-oxo-butanoate)
• 57905-31-4(Ethyl 4-hydroxynicotinate)
• 51559-52-5(methyl 2-(dimethylamino)methylidene-3-oxobutanoate)
• 609-70-1(4-hydroxypyridine-3-carboxylic acid)
• 74632-03-4(Diethyl 4-oxo-1,4-dihydro-3,5-pyridinedicarboxylate)
• 72676-96-1(3-Pyridinecarboxylicacid, 1,4-dihydro-4-oxo-)